{
    "url_original": "https://www.wsj.com/articles/johnson-johnson-asks-fda-to-authorize-covid-19-booster-11633442928?mod=business_lead_pos3",
    "url": "johnson-johnson-asks-fda-to-authorize-covid-19-booster-11633442928",
    "title": "Johnson & Johnson Asks FDA to Authorize Covid-19 Booster",
    "sub_head": "The extra dose increased protection to 94% against moderate to severe Covid-19 in a late-stage trial in the U.S., the company said",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-10-05 10:08:00",
    "body": "Johnson & Johnson  has asked U.S. health regulators to authorize a booster dose for its Covid-19 vaccine, citing studies showing it improved protection among adults who previously received a single shot.<br />The Food and Drug Administration could decide on J&Jâ€™s request within weeks. The agency has scheduled an Oct. 15 meeting of an advisory panel to review the evidence of the need for a booster, and to recommend whether the agency should authorize one."
}